Search

everythinglearnresearchcommunity

for

Search:↓

Desmoglein 3 is important for keeping hair follicle stem cells inactive and maintaining their special properties.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

New single-cell analysis techniques are improving our understanding of stem cells and could help in treating diseases.

Researchers developed a reliable method to measure testosterone and epitestosterone in urine for medical and anti-doping use.

Bioprinting could greatly improve health outcomes but faces challenges like material choice and ensuring long-term survival of printed tissues.

Two boys developed a viral skin infection during chemotherapy, which resolved with improved immune function.

Alopecia mucinosa on the face can be linked to mycosis fungoides, a type of lymphoma.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

Testosterone may influence COVID-19 severity and outcomes.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Ayurvedic treatment improved hair growth in a person with hair loss.

Stem cell plasticity is crucial for wound healing but can also contribute to cancer development.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.